New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Oncology March 30,2024
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Oncology March 30,2024
New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

by Jeff Hansen,University of Alabama at BirminghamMap of redlining in Birmingham, 1933. Credit: Public domain, Wikimedia CommonsA nationwide study of 196 cities shows that housing discrimination
Oncology March 30,2024
New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

by Jeff Hansen,University of Alabama at BirminghamMap of redlining in Birmingham, 1933. Credit: Public domain, Wikimedia CommonsA nationwide study of 196 cities shows that housing discrimination
Oncology March 30,2024
Discovery suggests new strategy against follicular lymphoma

Discovery suggests new strategy against follicular lymphoma

byWeill Cornell Medical CollegeGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.02.010A team led by researchers at Weill Cornell Medicine has identified import
Oncology March 30,2024
Discovery suggests new strategy against follicular lymphoma

Discovery suggests new strategy against follicular lymphoma

byWeill Cornell Medical CollegeGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.02.010A team led by researchers at Weill Cornell Medicine has identified import
Oncology March 30,2024
A combined PET-MRI scan could improve treatment for patients with early breast cancer

A combined PET-MRI scan could improve treatment for patients with early breast cancer

by European Organisation for Research and Treatment of CancerPhoto of researchers Dr. Rosa Di Micco & Professor Oreste Gentilini. Credit: EORTC / Rosa Di MiccoUsing a combined scanning technique o
Oncology March 30,2024
A combined PET-MRI scan could improve treatment for patients with early breast cancer

A combined PET-MRI scan could improve treatment for patients with early breast cancer

by European Organisation for Research and Treatment of CancerPhoto of researchers Dr. Rosa Di Micco & Professor Oreste Gentilini. Credit: EORTC / Rosa Di MiccoUsing a combined scanning technique o
Oncology March 30,2024
Researchers demonstrate technique for identifying single cancer cells in blood for the first time

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud
Oncology March 30,2024
Researchers demonstrate technique for identifying single cancer cells in blood for the first time

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud
Oncology March 30,2024
Unveiling gender differences in cancer: New insights into genomic instability

Unveiling gender differences in cancer: New insights into genomic instability

by Health Data ScienceScientists from Peking University Health Science Center investigated sex differences in genome instability across 16 cancer types, identifying male-biased and female-biased copy
Oncology March 30,2024
Unveiling gender differences in cancer: New insights into genomic instability

Unveiling gender differences in cancer: New insights into genomic instability

by Health Data ScienceScientists from Peking University Health Science Center investigated sex differences in genome instability across 16 cancer types, identifying male-biased and female-biased copy
Oncology March 30,2024
Exploring ferroptosis and its implications in lung cancer

Exploring ferroptosis and its implications in lung cancer

by Cactus CommunicationsEven with advances in diagnosis and treatments, the survival rate of patients with lung cancer, remains to be low. Ferroptosis is a type of iron-dependent programmed cell death
Oncology March 30,2024
Exploring ferroptosis and its implications in lung cancer

Exploring ferroptosis and its implications in lung cancer

by Cactus CommunicationsEven with advances in diagnosis and treatments, the survival rate of patients with lung cancer, remains to be low. Ferroptosis is a type of iron-dependent programmed cell death
Oncology March 30,2024
A new antibody capture method reveals G-quadruplex landscape and its regulation

A new antibody capture method reveals G-quadruplex landscape and its regulation

by Impact Journals LLCA comparative analysis of G4 landscape in cultured cells usingAbCG4-ChIP. (A) A schematic of the conventional G4-ChIP highlighting the possibilities of false positive
Oncology March 30,2024
A new antibody capture method reveals G-quadruplex landscape and its regulation

A new antibody capture method reveals G-quadruplex landscape and its regulation

by Impact Journals LLCA comparative analysis of G4 landscape in cultured cells usingAbCG4-ChIP. (A) A schematic of the conventional G4-ChIP highlighting the possibilities of false positive
Oncology March 30,2024
New review on p53 biology and reactivation in blood cancers

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C
Oncology March 30,2024
New review on p53 biology and reactivation in blood cancers

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C
Oncology March 30,2024
Researchers develop AI-based tool paving the way for personalized cancer treatments

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h
Oncology March 30,2024
Researchers develop AI-based tool paving the way for personalized cancer treatments

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com